CoChat

BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction

Open access
Shubin, Nicholas J, Chung, Chun S, Heffernan, Daithi S, Irwin, Lydea R, Monaghan, Sean F, Ayala, Alfred · 2012 · Journal of Leukocyte Biology
Cited by 95

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BTLA expression contributes to increased septic morbidity, mortality, and decreased innate cell activity in mice, while BTLA+ blood monocyte levels increase in septic ICU patients. A proper innate inflammatory response is essential for prevention of the systemic inflammation associated with sepsis. BTLA is an immune-regulatory receptor demonstrated to be expressed not only on adaptive immune populations and have potent inhibitory effects on CD4+ T cells but is also expressed on innate cell populations (CD11c+ and CD11b+ cells) and has been shown to diminish pathogen clearance following bacterial and parasite infection. The role of BTLA in sepsis and the mechanisms by which BTLA alters pathogen clearance, however, have not been addressed clearly. Here, we show that following acute experimental sepsis induction in mice (CLP), the number of infiltrating BTLA- and HVEM (the ligand for BTLA)-expressing macrophages, inflammatory monocytes, mature and immature DCs, and neutrophils increased in the peritoneum compared with sham surgery, suggesting that a high level of HVEM:BTLA interactions occurs between these cells at the site of septic insult. Given this, we evaluated BTLA−/− mice, 24 h post-CLP, and observed a marked increase in the degree of activation on these cell populations, as well as a reduction in peritoneal bacterial burden and IL-10 induction, and most importantly, BTLA−/− mice exhibited a higher rate of survival and protection from organ injury when compared with WT mice. Such changes were not restricted to experimental mice, as circulating BTLA+ and HVEM+ monocytes and HVEM+ granulocytes were increased in septic ICU patients, supporting a role for BTLA and/or HVEM as potential, novel diagnostic markers of innate immune response/status and as therapeutic targets of sepsis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1189/jlb.1211641

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 33

  1. Levy, 2003, 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference, Crit. Care Med., 31, 1250, 10.1097/01.CCM.0000050454.01978.3B · DOI · Paper page
  2. Bone, 1996, Sir Isaac Newton, sepsis, SIRS, and CARS, Crit. Care Med., 24, 1125, 10.1097/00003246-199607000-00010 · DOI · Paper page
  3. Ayala, 1994, Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production, J. Surg. Res., 56, 579, 10.1006/jsre.1994.1092 · DOI
  4. Huang, 2007, Changes in dendritic cell function in the immune response to sepsis. Cell- & tissue-based therapy, Expert Opin. Biol. Ther., 7, 929, 10.1517/14712598.7.7.929 · DOI
  5. Ayala, 1992, Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor), Circ. Shock, 36, 191
  6. Ellaban, 2004, Selective macrophage suppression during sepsis, Cell. Immunol., 231, 103, 10.1016/j.cellimm.2004.12.010 · DOI
  7. Newton, 2004, Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response, Surg. Infect. (Larchmt.), 5, 375, 10.1089/sur.2004.5.375 · DOI
  8. Del Rio, 2010, HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation, J. Leukoc. Biol., 87, 223, 10.1189/jlb.0809590 · DOI · Paper page
  9. Paulos, 2010, Putting the brakes on BTLA in T cell-mediated cancer immunotherapy, J. Clin. Invest., 120, 76, 10.1172/JCI41811 · DOI
  10. Adler, 2011, B and T Lymphocyte attenuator restricts the protective immune response against experimental malaria, J. Immunol., 187, 5310, 10.4049/jimmunol.1101456 · DOI · Paper page
  11. Hurchla, 2005, B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4 + T cells, J. Immunol., 174, 3377, 10.4049/jimmunol.174.6.3377 · DOI · Paper page
  12. Huang, 2009, PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis, Proc. Natl. Acad. Sci. USA., 106, 6303, 10.1073/pnas.0809422106 · DOI · Paper page
  13. Said, 2010, Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection, Nat. Med., 16, 452, 10.1038/nm.2106 · DOI · Paper page
  14. Zhang, 2010, PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction, Crit. Care., 14, R220, 10.1186/cc9354 · DOI · Paper page
  15. Sedy, 2005, B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator, Nat. Immunol., 6, 90, 10.1038/ni1144 · DOI · Paper page
  16. Ding, 2004, Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice, Shock, 22, 137, 10.1097/01.shk.0000131194.80038.3f · DOI
  17. Ocuin, 2011, Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis, J. Leukoc. Biol., 89, 423, 10.1189/jlb.0810479 · DOI
  18. Hu, 2009, The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock, J. Immunol., 182, 2467, 10.4049/jimmunol.0801463 · DOI
  19. Astiz, 1996, Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis, J. Lab. Clin. Med., 128, 594, 10.1016/S0022-2143(96)90132-8 · DOI
  20. Eggermont, 2011, New drugs in melanoma: It's a whole new world, Eur. J. Cancer., 47, 2150, 10.1016/j.ejca.2011.06.052 · DOI · Paper page
  21. Khaitan, 2011, Revisiting immune exhaustion during HIV infection, Curr. HIV/AIDS Rep., 8, 4, 10.1007/s11904-010-0066-0 · DOI · Paper page
  22. Reynoso, 2009, Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade, J. Immunol., 182, 2102, 10.4049/jimmunol.0802769 · DOI · Paper page
  23. Sakoda, 2011, Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway, Blood, 117, 2506, 10.1182/blood-2010-08-301325 · DOI · Paper page
  24. Blazar, 2003, Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism, J. Immunol., 171, 1272, 10.4049/jimmunol.171.3.1272 · DOI · Paper page
  25. Boomer, 2011, Immunosuppression in patients who die of sepsis and multiple organ failure, JAMA, 306, 2594, 10.1001/jama.2011.1829 · DOI · Paper page
  26. Brahmamdam, 2010, Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis, J. Leukoc. Biol., 88, 233, 10.1189/jlb.0110037 · DOI · Paper page
  27. Inoue, 2011, Dose Dependent Effect of Anti-CTLA-4 on Survival in Sepsis, Shock, 36, 38, 10.1097/SHK.0b013e3182168cce · DOI · Paper page
  28. Brown, 2010, Role of PD-1 in regulating acute infections, Curr. Opin. Immunol., 22, 397, 10.1016/j.coi.2010.03.007 · DOI · Paper page
  29. Guignant, 2011, Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients, Crit. Care, 15, R99, 10.1186/cc10112 · DOI · Paper page
  30. Pasero, 2009, A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production, Eur. J. Immunol., 39, 2502, 10.1002/eji.200939069 · DOI
  31. Hol, 2010, The murine IL-8 homologues KC, MIP-2, and LIX are found in endothelial cytoplasmic granules but not in Weibel-Palade bodies, J. Leukoc. Biol., 87, 501, 10.1189/jlb.0809532 · DOI · Paper page
  32. Nolan, 2009, Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis, PLoS One, 4, e6600, 10.1371/journal.pone.0006600 · DOI
  33. Laudanski, 2006, Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways, Proc. Natl. Acad. Sci. USA, 103, 15564, 10.1073/pnas.0607028103 · DOI

Cited by

Metadata

Authors
Shubin, N. J., Chung, C. S., Heffernan, D. S., Irwin, L. R., Monaghan, S. F., & Ayala, A.
Venue
Journal of Leukocyte Biology
Published
2012-03-29
Volume
92
Issue
3
Pages
593-603
ISSN
  • 0741-5400 (ISSN-L)
  • 1938-3673
OpenAlex
W2127148037
Cited by
95
References
5
FWCI
4.52
Type
journal article
Language
en
Open access
bronze
Funders
  • NIH (GM053209)
  • U.S. Department of Education (GAANN-P200A100100)
  • Armand D. Versaci Research Scholar in Surgical Sciences Award

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.